These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16112861)

  • 21. Nonsteroidal progesterone receptor ligands (I): synthesis and SAR of new tetrahydronaphthofuranone derivatives.
    Shinei R; Kurihara K; Tanabe K; Tabata Y; Kurata Y; Hoshiko S; Okonogi T
    Bioorg Med Chem; 2006 Jul; 14(14):4850-61. PubMed ID: 16580213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system.
    Adan RA
    Trends Pharmacol Sci; 2006 Apr; 27(4):183-6. PubMed ID: 16500715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New ligands at the melatonin binding site MT(3).
    Boussard MF; Truche S; Rousseau-Rojas A; Briss S; Descamps S; Droual M; Wierzbicki M; Ferry G; Audinot V; Delagrange P; Boutin JA
    Eur J Med Chem; 2006 Mar; 41(3):306-20. PubMed ID: 16414149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of a novel design paradigm to generate general nonpeptide combinatorial templates mimicking beta-turns: synthesis of ligands for melanocortin receptors.
    Webb TR; Jiang L; Sviridov S; Venegas RE; Vlaskina AV; McGrath D; Tucker J; Wang J; Deschenes A; Li R
    J Comb Chem; 2007; 9(4):704-10. PubMed ID: 17429950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards the development of mixed MT(1)-agonist/MT(2)-antagonist melatonin receptor ligands.
    Spadoni G; Bedini A; Guidi T; Tarzia G; Lucini V; Pannacci M; Fraschini F
    ChemMedChem; 2006 Oct; 1(10):1099-105. PubMed ID: 16955531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.
    Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1549-52. PubMed ID: 16386422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
    Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
    J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining 3D-QSAR, docking, molecular dynamics and MM/PBSA methods to predict binding modes for nonsteroidal selective modulator to glucocorticoid receptor.
    Xu Y; Zhang T; Chen M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):393-6. PubMed ID: 19081253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
    Singh P; Kaur P; Luxami V; Kaur S; Kumar S
    Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Privileged structure based ligands for melanocortin receptors--4,4-disubstituted piperidine derivatives.
    Kuklish SL; Backer RT; Briner K; Doecke CW; Husain S; Mullaney JT; Ornstein PL; Zgombick JM; O'Brien TP; Fisher MJ
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3843-6. PubMed ID: 16697186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction.
    Wikberg JE; Mutulis F
    Nat Rev Drug Discov; 2008 Apr; 7(4):307-23. PubMed ID: 18323849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of 3-(2-N,N-diethylaminoethoxy)indoles as potential 5-HT6 receptor ligands.
    Alex K; Schwarz N; Khedkar V; Sayyed IA; Tillack A; Michalik D; Holenz J; Díaz JL; Beller M
    Org Biomol Chem; 2008 May; 6(10):1802-7. PubMed ID: 18452016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New ligands for melanocortin receptors.
    Kaelin CB; Candille SI; Yu B; Jackson P; Thompson DA; Nix MA; Binkley J; Millhauser GL; Barsh GS
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S19-27. PubMed ID: 19136986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
    Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
    Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of 5-HT6 receptor ligands based on virtual HTS.
    Tasler S; Kraus J; Wuzik A; Müller O; Aschenbrenner A; Cubero E; Pascual R; Quintana-Ruiz JR; Dordal A; Mercè R; Codony X
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6224-9. PubMed ID: 17892934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. InBr3-promoted divergent approach to polysubstituted indoles and quinolines from 2-ethynylanilines: switch from an intramolecular cyclization to an intermolecular dimerization by a type of terminal substituent group.
    Sakai N; Annaka K; Fujita A; Sato A; Konakahara T
    J Org Chem; 2008 Jun; 73(11):4160-5. PubMed ID: 18442294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors.
    Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Hsu TA; Yueh A; Chao YS; Chern JH
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4134-8. PubMed ID: 19539472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the synthesis of indole and quinoline derivatives through cascade reactions.
    Barluenga J; Rodríguez F; Fañanás FJ
    Chem Asian J; 2009 Jul; 4(7):1036-48. PubMed ID: 19360759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability.
    Bulbule VJ; Rivas K; Verlinde CL; Van Voorhis WC; Gelb MH
    J Med Chem; 2008 Feb; 51(3):384-7. PubMed ID: 18198825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterocycle annulation of enolizable vinyl quinone imides. Dihydroquinolines and quinolines from thermal 6pi-electrocyclizations and indoles from photochemical cyclizations.
    Parker KA; Mindt TL
    Org Lett; 2002 Nov; 4(24):4265-8. PubMed ID: 12443074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.